β1 Integrin Adhesion Enhances IL-6―Mediated STAT3 Signaling in Myeloma Cells: Implications for Microenvironment Influence on Tumor Survival and Proliferation von SHAIN, Kenneth H, YARDE, Danielle N, MEADS, Mark B, MEI HUANG, JOVE, Richard, HAZLEHURST, Lori A, DALTON, William S

Volltext

Targeting the Fanconi anemia/BRCA pathway circumvents drug resistance in multiple myeloma von Yarde, Danielle N, Oliveira, Vasco, Mathews, Linda, Wang, Xingyu, Villagra, Alejandro, Boulware, David, Shain, Kenneth H, Hazlehurst, Lori A, Alsina, Melissa, Chen, Dung-Tsa, Beg, Amer A, Dalton, William S

Volltext

Increased expression of IL-18 in the serum and islets of type 1 diabetics von Harms, Robert Z., Yarde, Danielle N., Guinn, Zachary, Lorenzo-Arteaga, Kristina M., Corley, Kevin P., Cabrera, Monina S., Sarvetnick, Nora E.

Volltext

Oncolytic vesicular stomatitis virus and bortezomib are antagonistic against myeloma cells in vitro but have additive anti-myeloma activity in vivo von Yarde, Danielle N, Nace, Rebecca A, Russell, Stephen J

Volltext

CD28− CD8+ T cells are significantly reduced and correlate with disease duration in juveniles with type 1 diabetes von Yarde, Danielle N, Lorenzo-Arteaga, Kristina, Corley, Kevin P, Cabrera, Monina, Sarvetnick, Nora E

Volltext

Bortezomib salvage followed by a Phase I/II study of bortezomib plus high-dose melphalan and tandem autologous transplantation for patients with primary resistant myeloma von Nishihori, Taiga, Alekshun, Todd J., Shain, Kenneth, Sullivan, Daniel M., Baz, Rachid, Perez, Lia, Pidala, Joseph, Kharfan-Dabaja, Mohamed A., Ochoa-Bayona, Jose L., Fernandez, Hugo F., Yarde, Danielle N., Oliveira, Vasco, Fulp, William, Han, Gang, Kim, Jongphil, Chen, Dung-Tsa, Raychaudhuri, Jyoti, Dalton, William, Anasetti, Claudio, Alsina, Melissa

Volltext

Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV von Yarde, D N, Naik, S, Nace, R A, Peng, K-W, Federspiel, M J, Russell, S J

Volltext

Bortezomib salvage followed by a P hase I / II study of bortezomib plus high‐dose melphalan and tandem autologous transplantation for patients with primary resistant myeloma von Nishihori, Taiga, Alekshun, Todd J., Shain, Kenneth, Sullivan, Daniel M., Baz, Rachid, Perez, Lia, Pidala, Joseph, Kharfan‐Dabaja, Mohamed A., Ochoa‐Bayona, Jose L., Fernandez, Hugo F., Yarde, Danielle N., Oliveira, Vasco, Fulp, William, Han, Gang, Kim, Jongphil, Chen, Dung‐Tsa, Raychaudhuri, Jyoti, Dalton, William, Anasetti, Claudio, Alsina, Melissa

Volltext

Bortezomib Enhances Melphalan Response by Altering Fanconi Anemia (FA)/BRCA Pathway Expression and Function von Yarde, Danielle N., Hazlehurst, Lori A., Oliveira, Vasco A., Chen, Qing, Dalton, William S.

Volltext

Beta1 integrin adhesion enhances IL-6-mediated STAT3 signaling in myeloma cells: implications for microenvironment influence on tumor survival and proliferation von Shain, Kenneth H, Yarde, Danielle N, Meads, Mark B, Huang, Mei, Jove, Richard, Hazlehurst, Lori A, Dalton, William S

Volltext